Zydus launches India's first once-daily nebulised LAMA for COPD

Zydus launches India's first once-daily nebulised LAMA for COPD. The company introduced REVAHALE, a novel treatment for chronic obstructive pulmonary disease (COPD), marking a significant product launch in the respiratory therapeutics space. This positions Zydus as a pioneer in nebuliser-based maintenance therapy in India. The launch could drive future revenue growth and market share gains.

📊 STOCKS: $ZYDUSLIFE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma